Additional information
| Active substance | Levofloxacin | 
|---|---|
| Water Retention | No significant effect on water retention | 
| Hepatotoxicity | Rare, but potential for liver enzyme elevations | 
| Lab Test | Not specifically monitored via lab tests in standard clinical practice | 
| Strength | 250mg | 
| Also known as | L-isomer of Ofloxacin | 
| Blood pressure | No direct effects on blood pressure | 
| Trade name | Levaquin, Tavanic, and others | 
| Storage conditions | Store at room temperature away from moisture and heat | 
| Chemical name | (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 
| Formula | C18H20FN3O4 | 
| Substance class | Fluoroquinolone antibiotic | 
| Main action | Antibacterial | 
| Half-life | Approximately 6 to 8 hours | 
| Dosage (medical) | Typically 250 mg to 750 mg once daily, depending on the infection type and severity | 
| Dosage (sports) | Not applicable | 
| Effects | Effective against a broad range of gram-positive and gram-negative bacteria | 
| Side effects | Nausea, diarrhea, headache, dizziness, insomnia, and potential for tendon damage | 
| Use in sports | Not typically used in sports, misuse can lead to serious health risks | 
| Manufacturer | Cipla Ltd. | 
| Packing | 10 tabs/blister | 
 Balkan Pharma Cipandrol 250 mg 10 Ampere
							Balkan Pharma Cipandrol 250 mg 10 Ampere						 Omnacortil 30 mg Macleods
							Omnacortil 30 mg Macleods						 Spiriva HandiHaler 18mg Boehringer Ingelheim
							Spiriva HandiHaler 18mg Boehringer Ingelheim						 ABILIFY 10 mg Bristol - Myers Squibb
							ABILIFY 10 mg Bristol - Myers Squibb						




 
			 
			 
			 
			
Reviews
There are no reviews yet.